加速康复路径对直肠癌微创手术后肿瘤学结局的影响
该回顾性研究纳入2005年2月至2018年4月接受择期微创根治性手术的600例直肠腺癌成人患者,比较加速康复路径(ERP)与传统护理的短期并发症和生存结局。
要点
- ERP组总生存单因素改善但多因素分析无独立关联
- 无病生存两组相当,ERP对肿瘤学结局影响不明确
核心结论
- ERP治疗与较低的并发症风险相关,可能对总生存有微妙影响但对疾病特异性生存无影响。
临床怎么用
- 在直肠癌微创手术围术期管理中,实施ERP可降低总体并发症风险。
- ERP对总生存的潜在获益需结合多因素分析解读,不能视为独立预后因素。
局限性
- 回顾性研究设计可能引入选择偏倚和混杂因素。
- ERP对总生存的获益在多因素分析中未达统计学意义。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Oncological outcomes of locally advanced rectal cancer depend on the quality of surgical and oncological management. Enhanced recovery pathways (ERPs) have yet to be assessed for their oncological impact when used in combination with minimally invasive surgery. This study assessed outcomes with or without an ERP in patients with rectal cancer. METHODS: This was a retrospective analysis of all consecutive adult patients who underwent elective minimally invasive surgery for primary rectal adenocarcinoma with curative intent between February 2005 and April 2018. Both laparoscopic and robotic procedures were included. Short-term morbidity and overall survival were compared between patients treated according to the institutional ERP and those who received conventional care. RESULTS: A total of 600 patients underwent minimally invasive surgery, of whom 320 (53·3 per cent) were treated according to the ERP and 280 (46·7 per cent) received conventional care. ERP was associated with less overall morbidity (34·7 versus 54·3 per cent; P < 0·001). Patients in the ERP group had improved overall survival on univariable (91·4 versus 81·7 per cent at 5 years; hazard ratio (HR) 0·53, 95 per cent c.i. 0·28 to 0·99) but not multivariable (HR 0·78, 0·41 to 1·50) analysis. Multivariable analysis revealed age (HR 1·46, 1·17 to 1·82), male sex (HR 1·98, 1·05 to 3·70) and complications (HR 2·23, 1·30 to 3·83) as independent risk factors for compromised overall survival. Disease-free survival was comparable for patients who had ERP or conventional treatment (80·5 versus 84·6 per cent at 5 years respectively; P = 0·272). CONCLUSION: Treatment within an ERP was associated with a lower morbidity risk that may have had a subtle impact on overall but not disease-specific survival.
引用
- Quiram BJ, Crippa J, Grass F, et al. Impact of enhanced recovery on oncological outcomes following minimally invasive surgery for rectal cancer. Br J Surg. 2019. PMID: 30861099. doi:10.1002/bjs.11131
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。